RE: Pharma VC Invests in HEMO at 275% Premium2 Oct 2024 14:32
HEMO is corrected up here.
It been oversold for while
Prevail Partners, LLC ("Prevail Partners"), an investment fund, has agreed to invest a total of $350,000 (approximately £269,000) in the Company through a subscription for ordinary shares in the Company at a price of US$0.075 per share (approximately 5.6p).
Who says Prevail Partners not accummulating here? ... anyone
buying for tomorrow squueze, today was warning short to short and sellers. imho